Abstract
This article discusses the characteristics of the drug-resistant human cervical carcinoma cell line HeLa/MMC and investigates reversal effect of SDZ-PSC833(PSC833) and Verapamil (Ver) upon HeLa/MMC. Relative content of cell DNA detection, H3-TdR incorporation test and drug-resistance have been experimented, meanwhile a tumor transplant model in the nude mice for Hela/MMC has been established. Then the volume of cancer, tumor weight, curve line of growing up in tumor-bearing nude mouse and its morphological variation of carcinoma organism are observed to evaluate the reversal effect of PSC833 and VER. It has been found that: ➀ Compared with HeLa cells,subline HeLa/ MMC Cells’ drug-resistant capability against Mitomycin(MMC) or cisplatin(DDP) is as 5.02 folds or 2 folds as that of the former, respectively. The Hela/MMC cell line has characteristics of multi-drug resistance and stronger multiplication; ➁ PSC833 and VER can reverse resistance of HeLa/MMC to Mitomycin in vivo.PSC833 will be a better candidate for reversing multidrug resistant than verapamil in clinic application.
Similar content being viewed by others
References
Jean L M, Herve G, Muriel B H, et al. The Multidrug Resistance Modulator SDZ-PSC833 Potentiates the Photodynamic Activity of Chlorin e6 Independently of P-glycoprotein in Multidrug Resistant Human Breast Adenocarcinoma Cells [J]. Int J Oncology, 2003, 22: 733–739.
Xu B H, Gupta V, Sigh S V, et al. Characterization of a Human Bladder Cancer Cell Line Selected for Resistance to Mitomycin C [J]. Int J Cancer, 1994, 58:686–692.
Wu Zhongliang, Yang Hui, Gao Hongling, et al. The Effect of EMD upon DNA Content of A-549 Cell Line of Lung Cancer[J]. J Guangzhou Med, 1985, 13(3):10–12) (Ch).
Burres N S, Clement J J. Antitumor Activity and Mechanism of Action of the Novel Marine Natural Products Mycalamide-A and-B and Onnamide[J]. Cancer Res, 1989, 49: 2935–2940.
Merlin J L, Azzi S, Lignon D, et al. MTT Assays Allow Quick and Reliable Measurement of the Response of Human Tumour Cells to Photodynamic Therapy[J]. Eur J Cancer, 28A: 1992,1452–1458.
Watanabe T, Tsuge H, Hara T O, et al. Comparative Study on Reversal Efficacy of SDZ PSC833,Cyclosporin A and Verapamil on Multidrug Resistance in vitro and in vivo[J]. Acta Oncologica, 1995, 34: 235–241.
Sonneveld P, Burnett A, Vossebeld P, et al. Dose-Finding Study of Valspodar (PSC 833) With Daunorubicin and Cytarabine to Reverse Multidrug Resistancein Elderly Patients With Previously Untreated Acute Myeloidleukemia[J]. J Hematol 2000, 1: 411–421.
Bates S, Kang M, Meadows B, et al. A Phase I Study of Infusional Vinblastinein Combination with the P-Glycoprotein Antagonist PSC833(valspodar) [J]. Cancer, 2001, 92: 1577–1590.
Boesch D, Gaveriaux C, Jachez B, et al. In vivo Circumvention of P-GlyCoprotein Mediated Multidrug Resistance of Tumor Cells With SDZ-PSC833[J]. Cancer Res, 1991, 51: 4226–4233.
Beketic O L, Duraw G E, Chen G, et al. Decreased Mutation Rate For Celluar Resistance to Doxorubicin and Suppression of Mdr1 Gene Activation by the Cyclosporin PSC833[J]. J National Cancer Inst, 1995, 87(21): 1593–1602.
Colombo T, Paz O G, Incalci M D, et al. Distribution and Activity of Doxorubicin Combined With SDZ PSC833 in Mice With P388 and P388/DOX Leukaemia[J]. Br J Cancer, 1996, 73: 866–871.
Author information
Authors and Affiliations
Additional information
Foundation item: Supported by the Key Scientific and Technical Research Project of Hubei Provicial Department of Education (EK980038)
Biography: CHEN Hong(1965–), female, Associate professor, research direction: gynecological tumor.
Rights and permissions
About this article
Cite this article
Chen, H., Chen, H., Wu, X. et al. Reversal efficacy of SDZ-PSC833 and verapamil on drug-resistant human cervical carcinoma cells line. Wuhan Univ. J. of Nat. Sci. 12, 379–384 (2007). https://doi.org/10.1007/s11859-006-0065-6
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11859-006-0065-6